Quay Pharmaceuticals has the expertise and capabilities to formulate a wide range of products of behalf of global pharmaceutical and biopharmaceutical clients. We provide access to a variety of clinical manufacturing technologies and a wide range of dose forms, over-encapsulation, and novel drug delivery systems.
- High-shear mixers / granulators
- Planetary mixers
- Fluid bed processors
- Single punch, bilayer and high-speed rotary tablet presses
- Tablet-coating facilities for film, and enteric coating
- Bench top and automatic capsule filling equipment for powders, granules, liquids and semi-solids
- Tablet / capsule check weigher
- Topicals manufacturing facilities
- High-shear mixer / homogeniser for liquids and suspensions
- Manual liquid filling capabilities
- Comparator-blinding services, including encapsulation and coating
- Placebo development for use in blinded studies
Supporting these manufacturing operations, the pharmaceutical analysis laboratories can transfer-in, develop and validate test methods for Quality Control and ICH stability testing, as required.
The clinical manufacturing areas at Quay Pharmaceuticals operate to Good Manufacturing Practises and have been successfully audited by the Medicines and Healthcare products Regulatory Agency. Quay holds a Manufacturing Authorisation for the manufacture and testing of Investigational Medicinal Products (IMP's), as specified by the EU Clinical Trials Directive (2001/20/EC). In addition a 'Specials Manufacturing Licence' is also held.
Manufacturing scale to GMP averages 1 – 20kg or equivalent in volume terms. This is normally sufficient to support Phase I – II clinical studies.
For further information or to generally discuss your current or potential needs, contact:
Jill Jones - Operations Manager
Tel: +44 151 203 9800
E-Mail: j.jones@quaypharma.com